ASHLAND INC. COMMON STOCK

Ashland Board appoints Ashish K. Kulkarni as new director

08 May 2024 17:01:00 By Nasdaq GlobeNewswire

Ashland board authorizes quarterly dividend

07 May 2024 17:01:00 By Nasdaq GlobeNewswire

Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners

07 May 2024 06:59:00 By Nasdaq GlobeNewswire

Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024

30 Apr 2024 17:01:00 By Nasdaq GlobeNewswire

Ashland sets date for fiscal 2024 second-quarter earnings release and conference call webcast

18 Apr 2024 06:59:00 By Nasdaq GlobeNewswire

Ashland Board appoints Scott A. Tozier as new director

15 Apr 2024 06:59:00 By Nasdaq GlobeNewswire

Ashland announces executive organization changes to personal care and specialty additives

03 Apr 2024 17:01:00 By Nasdaq GlobeNewswire

Ashland drives gender parity, shines spotlight on the inspirational power of women from lab bench to real life, and announces Responsible Solvers™ speaker series

08 Mar 2024 06:59:00 By Nasdaq GlobeNewswire

Ashland reports financial results1 for first quarter fiscal 2024; issues outlook for second quarter and full-year fiscal 2024

30 Jan 2024 17:01:00 By Nasdaq GlobeNewswire

Ashland board authorizes quarterly dividend

22 Jan 2024 17:01:00 By Nasdaq GlobeNewswire

Ashland sets date for fiscal 2024 first-quarter earnings release and conference call webcast

16 Jan 2024 17:00:00 By Nasdaq GlobeNewswire

Ashland announces organization changes to finance and strategy, M&A and portfolio teams

09 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Ashland’s Carolmarie Brown tapped for top Women in Business by Delaware Today and the Delaware Business Times

04 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

Ashland announces validation of comprehensive science-based greenhouse gas emissions reductions targets

30 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Ashland publishes 2022 Environmental, Social and Governance Report online, sets stage for comprehensive Science Based Targets

21 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Ashland Board appoints Sanat Chattopadhyay, executive vice president, Merck & Company, as new director effective November 13, 2023

14 Nov 2023 17:25:00 By Nasdaq GlobeNewswire

Ashland board authorizes quarterly dividend

13 Nov 2023 17:00:00 By Nasdaq GlobeNewswire

Ashland reports financial results1 for fourth-quarter fiscal 2023; issues outlook for first-quarter fiscal 2024

08 Nov 2023 17:00:00 By Nasdaq GlobeNewswire

Ashland provides update on fiscal 2023 fourth-quarter and full-year earnings1 and announces upcoming portfolio-optimization actions; sets date for fiscal 2023 fourth-quarter earnings release

01 Nov 2023 17:00:00 By Nasdaq GlobeNewswire

Ashland changes start time for 2023 Innovation Day

28 Aug 2023 07:00:00 By Nasdaq GlobeNewswire